AXGN Q1 2024 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q1 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M+12.9% YoY

Gross Profit

$33M78.8% margin

Operating Income

-$5M-11.0% margin

Net Income

-$7M-16.0% margin

EPS (Diluted)

$-0.15

QoQ Revenue Growth

-3.6%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$14M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$187M

Total Liabilities

$93M

Stockholders' Equity

$93M

Cash & Equivalents

$16M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$37M	+12.9%
Gross Profit	$33M	$30M	+8.9%
Operating Income	-$5M	-$7M	+37.9%
Net Income	-$7M	-$7M	+6.2%